Form EFFECT ADIAL PHARMACEUTICALS,
- S&P 500, Nasdaq close up 4th straight week as optimism grows
- 'Back in Tech': Investors are Increasing Exposure to Tech and Growth Stocks - BofA
- Rivian Reports Bigger Loss, Says Current Models Won't Qualify for Tax Breaks
- US-listed China Stocks Slip on Delisting Moves, Analyst Sees Short-term Noise
- Salesforce (CRM), Snowflake (SNOW) Rated New Sell at Guggenheim, Oracle (ORCL) at Buy
News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
|SECURITIES AND EXCHANGE COMMISSION|
|Washington, D.C. 20549|
|Notice of Effectiveness|
|Effectiveness Date:||June 29, 2022|
|Submission Type:||POS AM|
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Laser Frenectomy Carver Langston, Ivy City Washington D.C. Update
- 2022 Taiwan Summer Tourism Festival Kicks Off For a Cool Summer
- Gary Perinar Re-Elected as Leader of 52,000-Member Mid-America Carpenters Regional Council
Create E-mail Alert Related CategoriesSEC Filings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!